A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer

Triple-negative breast cancer
DOI: 10.1021/acs.nanolett.7b00132 Publication Date: 2017-04-18T19:17:32Z
ABSTRACT
Ruthenium coordination complexes have the potential to serve as novel theranostic agents for cancer. However, a major limitation in their clinical implementation is effective tumor accumulation. In this study, we developed liposome-based nanodelivery system [Ru(phen)
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (121)